Corbus Pharmaceuticals Holdings Cash Flow Statement (2013-2025) | CRBP

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income (Quarter)
-20.98M-51.75M-53.96M-52.68M-10.43M-9.20M-23.16M-19.16M-10.57M-18.23M-28.96M-30.31M-10.72M0.19M-23.16M-18.11M1.85M-1.36M1.31M-24.42M
Depreciation and Depletion (Quarter)
0.28M0.27M0.26M0.26M0.21M0.20M0.19M0.19M0.18M0.18M0.20M0.20M0.10M0.20M0.20M0.20M0.10M0.10M0.10M0.10M
Share-based Compensation (Quarter)
2.34M2.58M2.51M2.60M1.79M1.59M1.51M1.35M1.27M1.03M0.82M0.82M0.80M0.98M0.00M0.00M1.63M1.71M0.00M8.30M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
0.61M
Cash from Restructuring (Quarter)
-0.17M-0.18M-0.18M-0.20M-0.20M-0.21M-0.22M-0.23M-0.23M-0.25M-0.26M-0.27M
Cash from Operations (Quarter)
-18.22M-21.81M-17.53M0.86M-9.70M-10.62M-12.23M-7.25M-7.45M-15.11M-7.80M-7.18M-6.01M-7.97M-8.94M-13.94M-10.94M-16.42M-16.60M-15.55M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.17M901.000.34M0.26M0.09M0.18M0.18M0.18M0.20M0.20M0.23M0.20M0.19M0.19M0.13M0.08M
Amortization of Deferred Charges (Quarter)
0.05M0.28M0.18M0.19M
Depreciation & Amortization (CF) (Quarter)
0.28M0.27M0.26M0.26M0.21M0.20M0.19M0.19M0.18M0.18M0.16M0.15M0.15M0.15M0.15M0.15M0.13M0.08M0.05M0.05M
Change in Working Capital
Change in Receivables (Quarter)
Change in Account Payables (Quarter)
-3.93M-3.69M-1.74M0.24M-0.76M0.57M-0.99M-0.81M0.98M-0.85M0.18M3.19M-1.50M-1.13M-0.90M1.95M1.68M-0.68M0.17M-1.28M
Change in Accured Expenses (Quarter)
-6.59M-4.26M-2.65M-1.47M-3.52M-4.60M-0.78M0.12M1.17M0.47M-0.05M1.13M3.48M-1.63M1.09M-3.33M-1.74M0.48M1.75M4.92M
Other Working Capital Changes (Quarter)
-0.23M-0.24M-0.25M-0.26M-0.26M-0.27M-0.28M-0.29M-0.29M-0.30M-0.32M-0.33M-0.33M-0.34M-0.36M-0.36M-0.37M-0.38M-0.40M-0.41M
Investing Activities
Capital Expenditures (Quarter)
-0.05M0.05M0.01M0.05M0.01M-0.21M0.00M
Sales of Property, Plant and Equipment (Quarter)
0.00M0.00M0.00M0.02M
Change in Acquisitions & Divestments (Quarter)
6.86M49.45M41.19M16.40M9.38M18.86M19.43M17.52M13.72M7.66M8.39M23.47M19.97M55.73M35.37M37.48M
Cash from Investing Activities (Quarter)
0.05M-57.42M-13.10M0.28M-3.18M42.96M-18.70M-5.97M11.78M5.55M8.81M10.90M10.39M-98.24M-16.44M-15.37M8.73M18.12M17.74M19.64M
Financing Activities
Other financing activities (Quarter)
Cash from Financing Activities (Quarter)
21.74M60.41M-0.26M-0.10M0.77M-0.33M-0.33M-0.11M0.23M-0.11M0.02M-0.82M-1.91M106.58M34.97M25.04M-0.01M2.85M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-99.10M62.54M0.04M0.11M0.01M-0.07M108.90M37.23M35.60M-0.01M2.85M
Additional items
Change in Cash (Quarter)
3.56M-18.82M-30.88M1.04M-12.11M32.02M-31.26M-13.33M4.56M-9.68M1.02M2.90M2.48M0.38M9.58M-4.26M-2.23M1.70M1.14M6.94M
Free Cash Flow (Quarter)
-18.17M-21.81M-17.53M0.86M-9.76M-10.63M-12.23M-7.25M-7.45M-15.11M-7.80M-7.22M-6.02M-7.75M-8.94M-13.94M-10.94M-16.42M-16.60M-15.55M
Net Cash Flow (Quarter)
3.56M-18.82M-30.88M1.04M-12.11M32.02M-31.26M-13.33M4.56M-9.68M1.02M2.90M2.48M0.38M9.58M-4.26M-2.23M1.70M1.14M6.94M